- Anthony Weiner on his current sexting habits: ‘None of your business’
- Producers eye Capitol Hill for latest reality TV hit
- No selfie awareness: Obama, Biden mug for Instagram as Ukraine implodes
- Putin to Snowden: We don’t collect droves of data on everyone like the U.S.
- Clemson football’s new opponent: Atheists upset with player prayer, Bible study
- Toronto Mayor Rob Ford’s re-election launch party will be ‘history in the making,’ brother says
- Louisiana group hits back at Sen. Mary Landrieu campaign ad with ‘Actress Mary’ spot
- Brain surgery victim struggles with Obamacare: ‘It’s scary’
- Pro-Russian forces storm Ukrainian national guard base; 3 killed
- Joe Biden’s first Instagram pic mocked as shill for sunglass ad
Study finds many patients shun free heart drugs
Roughly a year later, the share of patients who filled their prescriptions ranged from 36 percent to 49 percent in the copay group, depending on the drug, and was only 4 to 6 percentage points higher in the group that had no copays.
Providing these medicines for free had a “distressingly modest” effect on patients’ willingness to take them, Dr. Lee Goldman of Columbia University and Dr. Arnold Epstein of the Harvard School of Public Health wrote in an editorial in the medical journal.
The Commonwealth Fund, a foundation devoted to improving the health care system, helped pay for the study, and some of authors consult for insurance companies.
In the study, the total number of heart attacks, strokes, cases of chest pain or heart failure and other such problems was significantly lower in the group offered free medicine.
That meant that an additional 2 of every 100 people were spared such problems because they were offered free medicines. Doctors suspect the difference between the groups would have been greater if more people had actually filled their prescriptions.
Costs dropped 26 percent for patients in the free drug group compared with the others, partly because of fewer doctor visits, lab tests and hospitalizations.
After about a year, total medical costs for the insurer, including follow-ups, hospitalizations and doctor’s appointments, averaged $69,997 for those with the usual coverage and $64,726 for those offered free medicines. That was not considered a significant difference statistically, but insurers looking at the bottom line would still view it as worthwhile.
Dr. Lonny Reisman, an author of the study and chief medical officer for Aetna, said the company plans to offer some of these drugs free or with a reduced copay to some heart attack survivors and is considering doing do so for other chronic conditions such as diabetes and chronic lung disease.
The study may persuade other insurers to do the same, Goldman and Epstein said.
New England Journal: http://www.nejm.org
Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP
TWT Video Picks
By John R. Bolton
Reality calls for attaching Gaza to Egypt and the West Bank to Jordan
- 'Culture of intimidation' seen in Nevada ranch standoff
- Removal of military gear limits options for U.S., NATO in Ukraine
- IRS emails reveal discussion with Justice about suing nonprofits for election activities
- Rand and Ron Paul ride to the rescue for Bundy in Nevada standoff with feds
- NAPOLITANO: Hope for the dead and freedom for the living
- CURL: The state of the Union worse than you thought
- PETA officials collide with deer
- CNN op-ed claims right-wingers 'more deadly than jihadists'
- BOLTON: A 'three-state solution' for Middle East peace
- U.S. Navy to turn seawater into jet fuel
Celebrity deaths in 2014